National medical device inspection, start
Time:
2023-02-10
Xu Jinghe, a member of the Party Group and Deputy Director of the National Food and Drug Administration, emphasized the need to never relax, pay close attention to and effectively supervise the quality of medical devices, and fully ensure the quality and safety of medical devices used for epidemic prevention and control.
Xu Jinghe, a member of the Party Group and Deputy Director of the National Food and Drug Administration, emphasized the need to never relax, pay close attention to and effectively supervise the quality of medical devices, and fully ensure the quality and safety of medical devices used for epidemic prevention and control.
Medical device manufacturers for epidemic prevention and control should fully implement their main responsibilities, strengthen their sense of responsibility, and further enhance their awareness of responsibility implementation; To strengthen system management and ensure continuous compliance of the quality management system; To strengthen risk management, quality risks discovered should be dealt with as soon as possible.
Each provincial-level drug regulatory department should comply with the "four strictest" requirements, effectively implement local regulatory responsibilities, increase law enforcement inspections, product sampling, adverse event monitoring, and risk investigation efforts, strengthen linkage with relevant departments, and form a regulatory synergy.
Medical device manufacturers for epidemic prevention and control should fully implement their main responsibilities, strengthen their sense of responsibility, and further enhance their awareness of responsibility implementation; To strengthen system management and ensure continuous compliance of the quality management system; To strengthen risk management, quality risks discovered should be dealt with as soon as possible.
Each provincial-level drug regulatory department should comply with the "four strictest" requirements, effectively implement local regulatory responsibilities, increase law enforcement inspections, product sampling, adverse event monitoring, and risk investigation efforts, strengthen linkage with relevant departments, and form a regulatory synergy.